Speaker illustration

Doctor Masanari Kuwabara

Toranomon Hospital, Tokyo (Japan)

Member of:

European Society of Cardiology
Heart Failure Association

Masanari Kuwabara is currently a Chief Physician of Department of Cardiology in Toranomon Hospital, Tokyo, Japan. He graduated from Tottori University Medical School and received M.D. in 2007. He also received Ph.D. (Regenerative Medicine) from Tottori University Graduate School of Medical Science (Prof. Ichiro Hisatome) in 2014 and Ph.D. (Medicine, Epidemiology) from Jichi Medical University (Prof. Yosikazu Nakamura) in 2017. He finished postdoctoral fellowship at the University of Colorado Denver (Prof. Richard J. Johnson) in 2018. His expertise is in the field of cardiovascular prevention, especially uric acid and cardiovascular diseases, including hypertension, dyslipidemia, diabetes mellitus, metabolic syndrome, kidney diseases, and heart failure. He has received more than 20 awards from various academic societies and published more than 120 articles.

Xanthine oxidase inhibitors withdrawal syndrome

Event: ESC Congress 2023

Topic: Cardiotoxicity of Drugs

Session: Clinical pharmacology


Mortality and characteristics among four DOACs and warfarin.

Event: ESC Congress 2022

Topic: Anticoagulants

Session: Latest science in atrial fibrillation


Hyperfiltration could be a risk factor for development of hypertension: A five-year cohort study

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension mediated target organ damage and hypertension phenotypes


Optimal serum uric acid levels for hypertension:5-year cohort study

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension risk factors and life style


The effect of early intravenous immunoglobulin therapy for Kawasaki disease: 22nd nationwide survey in Japan

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations: Paediatric Cardiology

Session: Pregnancy


Obesity and serum uric acid as a risk factor for hypertension and diabetes mellitus: 5-year Japanese cohort study

Event: ESC Congress 2017

Topic: Hypertension, other

Session: Detecting and stratifying hypertension


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb